Traders purchased shares of Procter & Gamble Co (NYSE:PG) on weakness during trading on Wednesday. $174.13 million flowed into the stock on the tick-up and $123.53 million flowed out of the stock on the tick-down, for a money net flow of $50.60 million into the stock. Of all companies tracked, Procter & Gamble had the 17th highest net in-flow for the day. Procter & Gamble traded down ($1.27) for the day and closed at $77.04
A number of brokerages have weighed in on PG. Berenberg Bank began coverage on Procter & Gamble in a research report on Wednesday, February 28th. They issued a “sell” rating and a $78.50 price target for the company. Vetr raised Procter & Gamble from a “buy” rating to a “strong-buy” rating and set a $96.92 price target for the company in a research report on Thursday, February 1st. Stifel Nicolaus boosted their price target on Procter & Gamble from $87.00 to $88.00 and gave the stock a “hold” rating in a research report on Wednesday, January 24th. SunTrust Banks reaffirmed a “hold” rating and issued a $90.00 price target on shares of Procter & Gamble in a research report on Tuesday, January 23rd. Finally, JPMorgan Chase & Co. boosted their price objective on Procter & Gamble from $90.00 to $98.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 24th. One analyst has rated the stock with a sell rating, eight have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. Procter & Gamble currently has a consensus rating of “Buy” and an average price target of $87.18.
The company has a debt-to-equity ratio of 0.41, a current ratio of 0.94 and a quick ratio of 0.79. The firm has a market cap of $198,302.17, a PE ratio of 20.60, a price-to-earnings-growth ratio of 2.45 and a beta of 0.58.
Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, January 23rd. The company reported $1.19 EPS for the quarter, beating the consensus estimate of $1.14 by $0.05. The firm had revenue of $17.40 billion during the quarter, compared to analysts’ expectations of $17.39 billion. Procter & Gamble had a return on equity of 20.66% and a net margin of 15.34%. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.08 EPS. research analysts predict that Procter & Gamble Co will post 4.21 EPS for the current year.
In other Procter & Gamble news, Vice Chairman Jon R. Moeller sold 3,252 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $78.59, for a total value of $255,574.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Marylynn Fergusonmchugh sold 2,353 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $78.59, for a total value of $184,922.27. The disclosure for this sale can be found here. In the last ninety days, insiders sold 114,011 shares of company stock valued at $9,710,976. Insiders own 0.35% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Signature Estate & Investment Advisors LLC bought a new stake in Procter & Gamble during the 4th quarter worth approximately $103,000. Earnest Partners LLC bought a new stake in Procter & Gamble during the 4th quarter worth approximately $110,000. Harding Loevner LP bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $119,000. Cerebellum GP LLC bought a new stake in Procter & Gamble during the 4th quarter worth approximately $122,000. Finally, Kohmann Bosshard Financial Services LLC bought a new stake in Procter & Gamble during the 3rd quarter worth approximately $125,000. Institutional investors own 60.95% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/03/21/investors-buy-procter-gamble-pg-on-weakness.html.
Procter & Gamble Company Profile
The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.